Retrieved on:
Thursday, December 1, 2022
Hershel and the Hanukkah Goblins,
COVID-19,
Learning,
Poverty,
Magic,
History,
Clothing,
Geography,
Hospital,
Student,
School,
Andrews McMeel Publishing,
A Visit from St. Nicholas,
Andrews McMeel Universal,
Parent,
Book,
Child,
Holiday,
Publishing,
Hershel of Ostropol,
Calendar,
The Walt Disney Company,
Family,
Collection,
Freedom,
Reading,
Safety,
Toy,
Entertainment,
Epic REDWOOD CITY, Calif., Dec. 1, 2022 /PRNewswire/ -- To celebrate the holiday season and in the spirit of giving and learning, Epic, the leading digital reading platform for kids, has announced this year's holiday collection and give-back campaign, Cozy Up & Read. Epic has partnered with Andrews McMeel Publishing and Baby2Baby to donate 2,000 books to kids in need with each gifting of or upgrade to Epic Unlimited this holiday season.
Key Points:
- Epic partners with Andrews McMeel Publishing and Baby2Baby to gift thousands of new books to children in need with every new Epic subscription this holiday season.
- Epic has partnered with Andrews McMeel Publishing and Baby2Baby to donate 2,000 books to kids in need with each gifting of or upgrade to Epic Unlimited this holiday season.
- This holiday season, the gift of reading for kids is also a gift of freedom for parents.
- "At Epic, we understand the importance of reading for young children and want to inspire learning this holiday season through this specially curated collection of books.
Retrieved on:
Thursday, September 22, 2022
Health,
Center,
COVID-19,
Medicare,
COVID-19 deaths,
Research,
Vaccination,
Organization,
Population,
Health information management,
Patient,
Risk,
Medicaid,
Weekly,
Death,
Multimedia,
Disease,
Pharmaceutical industry,
Hospital,
Epic,
Cosmos VERONA, Wis., Sept. 22, 2022 /PRNewswire/ -- A new study from Epic Research shows that the anti-viral treatment Paxlovid can meaningfully reduce COVID-19-related hospitalizations and deaths— even among patients under the age of 65. The rapid treatment of high-risk patients with Paxlovid, as well as receipt of prior COVID-19 vaccination, can have a critical lifesaving benefit in preventing the potentially deadly effects of COVID-19.
Key Points:
- VERONA, Wis., Sept. 22, 2022 /PRNewswire/ -- A new study from Epic Research shows that the anti-viral treatment Paxlovid can meaningfully reduce COVID-19-related hospitalizations and deaths even among patients under the age of 65.
- The rapid treatment of high-risk patients with Paxlovid, as well as receipt of prior COVID-19 vaccination , can have a critical lifesaving benefit in preventing the potentially deadly effects of COVID-19.
- The study found that:
Patients who received Paxlovid were two times less likely to be hospitalized for COVID-19 and four times less likely to die of COVID-19 than those who didn't.
- "Our study shows that Paxlovid helps to reduce COVID-19 deaths and hospitalizations significantly," said Jackie Gerhart, vice president of clinical informatics at Epic and an author on the study.
Retrieved on:
Wednesday, September 14, 2022
Cosmos,
Clinical trial,
Research,
List of life sciences,
Organization,
Friction,
News,
Epic,
Patient,
CRO,
Multimedia,
Efficiency,
Edwards Lifesciences,
View,
Program,
Reliance Institute of Life Sciences,
Pharmaceutical industry,
Online shopping VERONA, Wis., Sept. 14, 2022 /PRNewswire/ -- Epic announces the release of its Life Sciences program, expanding its work to bring together the disconnected parts of healthcare. The program is built to help providers, pharmaceutical companies, and medical device manufacturers recruit research participants, expand clinical trial access to underrepresented communities, and speed up the development of new therapies.
Key Points:
- "The Life Sciences program is designed to create a seamless connection between participant patients, healthcare providers, and research sponsors through the use of a single system," said Alan Hutchison, vice president at Epic.
- "Unifying clinical research with care delivery and building a direct connection to study sponsors will help accelerate the development of new therapies by making studies more efficient, more accessible, and more effective."
- "The first stage of the Life Sciences program, clinical trial matchmaking, is available today and provider organizations in the Epic community are already signing up," said Seth Howard, vice president of research and development at Epic.
- Provider organizations in the Epic community and life sciences groups that are interested in study feasibility and clinical trial matchmaking can reach out to [email protected] to learn more.
Efficiency,
Diagnosis,
Health,
Artificial intelligence,
Patient,
Protein,
Research,
Precision medicine,
American Securities,
Cancer,
Blood,
Disease,
Oncology,
Health information management,
Population,
Exome,
MBA,
Partnership,
EHR,
ORA,
RNA,
DNA,
Drug development,
Twitter,
Physician,
Epic,
Population health,
Education,
Dentistry,
Medical imaging IRVING, Texas, July 7, 2022 /PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize health care, today announced an enhanced partnership with Epic, a leader in software systems for electronic health records (EHR), to integrate Caris' market leading molecular testing portfolio with Epic's Orders and Results Anywhere (ORA) network.
Key Points:
- "Building on the success of our Epic Genomics Module integration, ORA will further enhance patient access to critical molecular results they need to fight, and hopefully beat cancer."
- "Integrations like ours with Caris Life Sciences directly benefit patients by improving access and efficiency to testing results that lead to informed treatment decisions," said Alan Hutchison, Vice President of Population Health at Epic.
- "We are excited for this enhanced partnership with Caris to further increase health access and care, and the opportunity to help deliver precision medicine to a greater number of communities."
- Caris Life Sciences(Caris) is the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare and improve patient outcomes.
VERONA, Wis., June 16, 2022 /PRNewswire/ -- Epic is announcing its plan to join a new health information exchange framework to improve health data interoperability across the country. The Trusted Exchange Framework and Common Agreement (TEFCA) will bring information networks together to help ensure that all people benefit from complete, longitudinal health records wherever they receive care. In the future, TEFCA will expand to support use cases beyond clinical care, such as public health.
Key Points:
- In the future, TEFCA will expand to support use cases beyond clinical care, such as public health.
- Epic collaborated with ONC, The Sequoia Project, and the broader healthcare community to build consensus around the principles and procedures of TEFCA.
- When the application process opens later this year, Epic will apply to join TEFCA as an inaugural Qualified Health Information Network.
- "Our customers have led the way with large-scale interoperability through Carequality, and we're happy to help with the next stage in the evolution of interoperability."
Office of Inspector General, U.S. Department of Health and Human Services,
Prescription,
Government,
COVID-19 policy of the Joe Biden administration,
COVID-19,
HHS,
MD,
Test,
Patient,
Pharmacy,
White,
White House,
Administration,
FDA,
Pharmaceutical industry,
Epic VERONA, Wis., April 26, 2022 /PRNewswire/ -- When the Biden Administration launched the Test to Treat initiative in early March, it took the first step toward making COVID-19 antiviral treatments easier for patients and providers to find. Currently, patients can go to more than 2,200 Test to Treat facilities across the country to get tested for COVID-19, receive prescriptions for treatments when appropriate, and have their prescriptions filled—all under a single roof. Now, as the Biden Administration works to double the number of pharmacies that carry COVID-19 treatments, providers can use Epic to determine which pharmacies have the treatments in stock and guide patients to those pharmacies for more timely and effective care.
Key Points:
- Now, as the Biden Administration works to double the number of pharmacies that carry COVID-19 treatments, providers can use Epic to determine which pharmacies have the treatments in stock and guide patients to those pharmacies for more timely and effective care.
- "Through Epic, providers can more easily connect patients to lifesaving treatments as the Administration significantly increases the number of pharmacies that carry those treatments."
- As the government has worked to increase access to COVID-19 treatments, ensuring that providers know which pharmacies have those treatments in stock has been a challenge.
- Three Epic enhancements mitigate that challenge and help providers connect patients with COVID-19 treatments more effectively:
Treatment information at a glance.
Retrieved on:
Wednesday, April 13, 2022
Center,
Antimicrobial stewardship,
Korea Disease Control and Prevention Agency,
Myocarditis,
The New England Journal of Medicine,
Population,
CDC,
COVID-19,
Pediatrics,
Morbidity and Mortality Weekly Report,
MD,
Infection,
Disease,
Vaccination,
Vaccine,
Violence,
Diabetes Care,
Public health,
Multimedia,
Decision-making,
Risk,
Hospital,
Severe acute respiratory syndrome coronavirus 2,
Research,
Pharmaceutical industry,
Cosmos,
Epic VERONA, Wis., April 13, 2022 /PRNewswire/ -- In a new Morbidity and Mortality Weekly Report published by the Centers for Disease Control and Prevention (CDC), researchers from the CDC and Epic found that among people previously infected with SARS-CoV-2, vaccination offers the best protection against reinfections that result in hospitalizations. This finding is consistent with previous evidence that vaccination-induced immunity combined with infection-induced immunity provides better protection than infection-induced immunity alone. The new report presents an analysis of data from Epic's Cosmos database, a large electronic health record database that is broadly representative of the U.S. population.
Key Points:
- This finding is consistent with previous evidence that vaccination-induced immunity combined with infection-induced immunity provides better protection than infection-induced immunity alone.
- The new report presents an analysis of data from Epic's Cosmos database, a large electronic health record database that is broadly representative of the U.S. population.
- Cosmos allows researchers to study 138 million deidentified patient records that account for more than 4 billion healthcare encounters nationwide.
- To learn more about Cosmos and Epic, visit https://cosmos.epic.com/ and www.epic.com/about
View original content to download multimedia: https://www.prnewswire.com/news-releases/youve-had-covid-19-should-you-s...
Heres,
Change Healthcare,
Patient,
View,
KLAS,
Wolters Kluwer,
Multimedia,
American Medical Association,
Time,
Intelligent Medical Objects,
Connect,
Healthwise,
Indian Medical Association,
Physician,
Software as a service,
Operation Garden Plot,
Software,
Los Alamos National Laboratory,
Medical device,
Risk management,
Sphere,
Biscom,
Service,
Anjunabeats,
Epic,
Surescripts,
High-availability cluster VERONA, Wis., March 8, 2022 /PRNewswire/ -- In 2020, the American Medical Association found that nearly half of US physicians worked in independent medical groups.
Key Points:
- VERONA, Wis., March 8, 2022 /PRNewswire/ -- In 2020, the American Medical Association found that nearly half of US physicians worked in independent medical groups.
- To streamline access to its industry-leading suite, Epic has released a new Software as a Service (SaaS) offering called Garden Plot.
- "We're excited to give more clinicians the opportunity to use Epic software," said JP Heres, vice president of Garden Plot at Epic.
- Almost 40,000 providers use Epic through Connect, which Epic recommends to medical groups because it creates shared patient records with local hospitals.
Boston,
Partnership,
Creativity,
Deloitte,
Twitter,
SVP,
Exam proctoring,
Fast Company,
Nursing,
Organization,
Clinical professor,
Boston Business Journal,
Business,
Johns Hopkins Hospital,
Multimedia,
Cleveland,
View,
Cleveland Clinic,
Solution,
Mayo Clinic,
Software,
Medicine,
Online shopping "We are excited to expand our relationship with Examity," said Shannon Kirby-Amacher, Global Training Coordinator, Epic.
Key Points:
- "We are excited to expand our relationship with Examity," said Shannon Kirby-Amacher, Global Training Coordinator, Epic.
- "They have been a true partner who consistently deliver a great experience for our test-takers as well as our administrators.
- An Examity partner since 2018, Epic is expanding its work with the proctoring platform to improve the test-taking experience.
- Since 2013, Examity has partnered with hundreds of organizations worldwide to provide a cost-effective and flexible online proctoring solution.
Retrieved on:
Wednesday, February 9, 2022
SAN FRANCISCO, Feb. 9, 2022 /PRNewswire/ -- PayZen , a mission-driven fintech company tackling healthcare affordability, today announced that its technology has been approved by Epic to offer its "Care Now, Pay Later" solution on the App Orchard Marketplace.
Key Points:
- SAN FRANCISCO, Feb. 9, 2022 /PRNewswire/ -- PayZen , a mission-driven fintech company tackling healthcare affordability, today announced that its technology has been approved by Epic to offer its "Care Now, Pay Later" solution on the App Orchard Marketplace.
- PayZen's first-of-its-kind, AI-backed technology allows hospitals, health systems and large physician groups to offer its patients affordable payment options, while accurately determining a patient's unique ability to pay.
- Offering the integrated solution on the Epic platform will provide a seamless solution to providers who use Epic and a superior user experience for their patients.
- PayZen is a mission-driven healthcare fintech company that aims to tackle the growing patient payment responsibility problem with superior technology and a modern approach.
